Notch is active in Langerhans cell histiocytosis and confers pathognomonic features on dendritic cells

Blood

Volumn 120, Issue 26, 2012, Pages 5199-5208

  Hutter, Caroline ^a,b   Kauer, Max ^b   Simonitsch Klupp, Ingrid ^a   Jug, Gunhild ^b   Schwentner, Raphaela ^b   Leitner, Judith ^c   Bock, Peter ^d   Steinberger, Peter ^c   Bauer, Wolfgang ^e   Carlesso, Nadia ^f   Minkov, Milen ^a,b   Gadner, Helmut ^a,b   Stingl, Georg ^e   Kovar, Heinrich ^b   Kriehuber, Ernst ^e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d DANUBE HOSPITAL   (Austria)

^e Universitatsklinik fur Dermatologie   (Austria)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MEMBRANE PROTEIN; METALLOPROTEINASE; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PROTEIN ADAMDEC1; PROTEIN JAGGED2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LANGERHANS CELL; LANGERHANS CELL HISTIOCYTOSIS; MALE; MONOCYTE; MYELOID DENDRITIC CELL; NUCLEOTIDE SEQUENCE; ONTOGENY; PATHOGENESIS; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION;

EID: 84871583494     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-410241     Document Type: Article

References (50)

1. Laman JD, Leenen PJ, Annels NE, Hogendoorn PC, Egeler RM. Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol. 2003;24(4):190-196.
2. Weitzman S, Egeler RM. Langerhans cell histiocytosis: update for the pediatrician. Curr Opin Pediatr. 2008;20(1):23-29.
3. Gadner H, Grois N, Potschger U, et al. Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood. 2008;111(5):2556-2562.
4. Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ. Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol. 2012;156(2):163-172.
5. Badalian-Very G, Vergilio J-A, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919-1923.
6. Allen CE, Li L, Peters TL, et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010;184(8):4557-4567.
7. Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010;116(16):e74-80.
8. Kriehuber E, Breiteneder-Geleff S, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med. 2001;194(6):797-808. (Pubitemid 32983015)
9. Kauer M, Ban J, Kofler R, et al. A molecular function map of Ewing's sarcoma. PLoS ONE. 2009;4(4):e5415.
10. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
11. Kestler HA, Muller A, Kraus JM, et al. VennMaster: area-proportional Euler diagrams for functional GO analysis of microarrays. BMC Bioinformatics. 2008;9:67.
12. Chott A, Haedicke W, Mosberger I, et al. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol. 1998;153(5):1483-1490. (Pubitemid 28509905)
13. Fernandez L, Rodriguez S, Huang H, et al. Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp Hematol. 2008;36(5):545-558.
14. Höflinger S, Kesavan K, Fuxa M, et al. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors. J Immunol. 2004;173(6):3935-3944. (Pubitemid 39280757)
15. Kriehuber E, Bauer W, Charbonnier AS, et al. Balance between NF-kappaB and JNK/AP-1 activity controls dendritic cell life and death. Blood. 2005;106(1):175-183. (Pubitemid 40967190)
16. Szabolcs P, Moore MA, Young JW. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol. 1995;154(11):5851-5861.
17. Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer. 2010;10(2):116-129.
18. Waskow C, Liu K, Darrasse-Jeze G, et al. The receptor tyrosine kinase FLT3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008;9(6):676-683. (Pubitemid 351712638)
19. Ginhoux F, Liu K, Helft J, et al. The origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med. 2009;206(13):3115-3130.
20. Xie MH, Aggarwal S, Ho WH, et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem. 2000;275(40):31335-31339.
21. Baatar D, Patel K, Taub DD. The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 2011;340(1):44-58.
22. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52-67.
23. Rust R, Kluiver J, Visser L, et al. Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis. J Pathol. 2006;209(4):474-483. (Pubitemid 44194562)
24. Gonzalvez F, Ashkenazi A. New insights into apoptosis signaling by Apo2L/TRAIL. Oncogene. 2010;29(34):4752-4765.
25. Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system. Immunity. 2010;32(1):14-27.
26. Cheng P, Zhou J, Gabrilovich D. Regulation of dendritic cell differentiation and function by Notch and Wnt pathways. Immunol Rev. 2010;234(1):105-119.
27. Geissmann F, Emile JF, Andry P, et al. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J Pathol. 1997;181(3):301-304. (Pubitemid 27156843)
28. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature. 1993;361(6407):82-85. (Pubitemid 23020779)
29. Bahar-Shany K, Ravid A, Koren R. Upregulation of MMP-9 production by TNFalpha in keratinocytes and its attenuation by vitamin D. J Cell Physiol. 2010;222(3):729-737.
30. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284(5421):1835-1837.
31. Klechevsky E, Liu M, Morita R, et al. Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines. Hum Immunol. 2009;70(5):281-288.
32. Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol. 2008;8(12):935-947.
33. Geissmann F. Differentiation of Langerhans cells in Langerhans cell histiocytosis. Blood. 2001;97(5):1241-1248. (Pubitemid 32183745)
34. Swerdlow S, Campo E, Harris NL, eds; International Agency for Research on Cancer. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. Geneva: World Health Organization; 2008.
35. Ohishi K, Varnum-Finney B, Serda RE, Anasetti C, Bernstein ID. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood. 2001;98(5):1402-1407.
36. Bugeon L, Gardner LM, Rose A, Gentle M, Dallman MJ. Cutting edge: Notch signaling induces a distinct cytokine profile in dendritic cells that supports T cell-mediated regulation and IL-2-dependent IL-17 production. J Immunol. 2008; 181(12):8189-8193.
37. Pérez-Cabezas B, Naranjo-Gomez M, Bastos-Amador P, Requena-Fernandez G, Pujol-Borrell R, Borras FE. Ligation of Notch receptors in human conventional and plasmacytoid dendritic cells differentially regulates cytokine and chemokine secretion and modulates Th cell polarization. J Immunol. 2011;186(12):7006-7115.
38. Weijzen S, Velders MP, Elmishad AG, et al. The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J Immunol. 2002;169(8):4273-4278. (Pubitemid 35178199)
39. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med. 1998;187(6):961-966. (Pubitemid 28141669)
40. Van de Walle I, De Smet G, Gartner M, et al. Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions. Blood. 2011;117(17):4449-4459.
41. Leenen PJ, Egeler RM. Langerhans' cell histiocytosis is caused by dysregulation of the E-cadherin-beta-catenin cascade: a hypothesis. Immunol Cell Biol. 1999;77(5):460-467. (Pubitemid 29476917)
42. Radke AL, Reynolds LE, Melo RC, Dvorak AM, Weller PF, Spencer LA. Mature human eosinophils express functional Notch ligands mediating eosinophil autocrine regulation. Blood. 2009;113(13):3092-3101.
43. Zhang B, Liu R, Shi D, et al. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood. 2009;113(1):46-57.
44. Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI. Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. Blood. 2007;109(2):507-515. (Pubitemid 46105947)
45. Senechal B, Elain G, Jeziorski E, et al. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis. PLoS Med. 2007;4(8):e253.
46. Skokos D, Nussenzweig MC. CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med. 2007;204(7):1525-1531. (Pubitemid 47048020)
47. Sprinzak D, Lakhanpal A, Lebon L, et al. Cis-interactions between Notch and Delta generate mutually exclusive signalling states. Nature. 2010;465(7294):86-90.
48. da Costa CET. Presence of osteoclast-like multi-nucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis. J Exp Med. 2005;201(5):687-693.
49. Minkov M. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatr Drugs. 2011;13(2):75-86.
50. Rodig SJ, Payne EG, Degar BA, et al. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol. 2008;83(2):116-121.